Five thousand thirty-nine of five thousand two hundred seventeen patients included in the GCKD study had complete baseline data on age, sex, eGFRcys, UACR, apoA-IV concentrations, cancer information and follow-up data available. This evidence concerns the gene APOA4 and cancer.